Current Surgical News Today

/PRNewswire/ -- Current Surgical Inc., a medical technology company developing a new surgical platform to improve the safety and efficacy of cancer surgery,...

From smartphones to smart cars and smart homes, now this D.C.-based start-up company is attempting to release the "smart needle." Smart needles seem only appropriate as we inch closer to a seemingly sci-fi-based reality with neuralink, ChatGPT and quantum computing. Remarkably, this development, unlike the catastrophic undertones of ChatGPT, is a positive one that can

Smart needles could help reduce the need for typical cancer treatments such as invasive surgery, radiation or chemotherapy. Kurt "CyberGuy" Knutsson explains.

The DC startup, which operates out of the DC JLabs location, is attempting to build a tumor-destroying system that can work through a needle.

Actuator: Two days in the Bay. Corporate research institutes, the problem with humanoids and a little ChatGPT as a treat

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

D.C.-based Current Surgical this week announced a $3.2 million seed. The round brings the firm’s total raise up to $4 million,

/PRNewswire/ -- Current Surgical Inc. today announced a $3.2 million seed funding round led by True Ventures, with participation from 1517 Fund and SciFounders....

Current Surgical earned $3.2 million to create a 'smart needle' to treat malignant tumors.

These 16 biotech investors are all in their first decade of working in venture capital and bringing fresh perspectives to the world of biotech.